Chart, page-4651

I think this has been the major reason for taking things slowly. They want EMA and US together if possible or at least give it a good shot..

Now how can any Pharma not interested if this is happening??

Too much at stake and hence I believe that once the FDA feedback comes out that would make the path/ process somewhat clear for harmonizing..

Isn't it too much risk to let this go and let ANP go all alone) . TBH They are not even capable to do this by themselves ...All brokers report are suggesting 55c to 70c with just EMA into consideration, not add to that the US market and we are looking at close to $1..

Genuine bargain and accumulation opportunity ..IMO

DYOR